✦ LIBER ✦

P.342 20 year follow-up of hepatitis B vaccination in the institutionalized mentally retarded

✍ Scribed by P. Van Damme; K. Van Herck; M. Van der Wielen; S. Broodhaers; T. Bauer; W. Jilg

Book ID: 117770552
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 144 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80516-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nine-year post-immunization follow up on

Nine-year post-immunization follow up on hepatitis B vaccination in institutionalized mentally-impaired patients

✍ DL Smalley; HH Pyun; MA Umstot; B Waters; SJ Sargent 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 225 KB

P.352 Efficacy of hepatitis B vaccine in

P.352 Efficacy of hepatitis B vaccine in preventing clinical hepatitis B in children: a 13 years follow-up

✍ J. Gong; R.C. Li; J.Y. Yang; X.R. Chen; C.B. Liu; K. Zhao 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Persistence of anti-HBs in children vacc

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years

✍ G. Da Villa; F. Peluso; L. Picciotto; M. Bencivenga; S. Elia; M.G. Pelliccia 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Evaluation of the immunologic response t

Evaluation of the immunologic response to hepatitis B vaccine in health care workers at an university hospital: five-year follow-up

✍ R.S.B. Stucchi; M.S.K. Lazarini; G.C. Zen; F.L. Gonçales Jr 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Long-term persistence of antibodies indu

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

✍ P. Van Damme; G. Leroux-Roels; B. Law; F. Diaz-Mitoma; I. Desombere; F. Collard; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Abstract It is important to monitor the long‐term persistence of antibodies induced by vaccination. Four cohorts were followed for their long‐term immunity after vaccination with a combined hepatitis A and B vaccine (Twinrix; SmithKline Beecham Biologicals, Rixsenart, Belgium). Two cohorts of ad